Compound Detail
CHEMBL567
PERPHENAZINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL567 |
| Name | PERPHENAZINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | RGCVKNLCSQQDEP-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
43
Targets
61
Activities
3
Assay Types
8
PK Parameters
20
Publications
10
Known Names
9
Indications
1
Mechanisms
Molecular Properties
404.0
MW (Da)
3.94
ALogP
5
HBA
1
HBD
29.9
PSA (Ų)
0.79
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1957 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor antagonist | ANTAGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Postoperative Nausea and Vomiting Psychotic Disorders Schizophrenia Anxiety Dementia Depressive Disorder Psychomotor Agitation Cocaine-Related Disorders Ischemic Stroke
ATC Classification
N05AB03
perphenazine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Drug Warnings
Black Box Warning
psychiatric toxicity
Black Box Warning
General Warning
Activity Summary
IC50 53 meas. best 9.52
EC50 6 meas. best 5.3
Ki 2 meas. best 7.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL217 | IC50 | 9.52 | 9.52 | 0.3 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 7.64 | 7.64 | 23.0 | 1 |
| Aldehyde oxidase CHEMBL3257 | IC50 | 7.48 | 7.48 | 33.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| Aldehyde dehydrogenase 1A1 CHEMBL3577 | IC50 | 6.28 | 6.28 | 524.2 | 1 |
| Aldehyde oxidase 1 CHEMBL1641355 | IC50 | 6.13 | 6.13 | 740.0 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs CHEMBL1697658 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.6 | 5.3857 | 2511.9 | 7 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 5.56 | 5.56 | 2774.5 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 5.56 | 5.56 | 2777.1 | 1 |
| CX3C chemokine receptor 1 CHEMBL4843 | IC50 | 5.53 | 5.53 | 2949.1 | 1 |
| Apelin receptor CHEMBL1628481 | IC50 | 5.49 | 5.49 | 3217.7 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 5.46 | 5.46 | 3454.1 | 1 |
| Aldehyde oxidase 1 CHEMBL1641357 | IC50 | 5.44 | 5.44 | 3600.0 | 1 |
| Glucagon-like peptide 1 receptor CHEMBL1784 | IC50 | 5.41 | 5.41 | 3931.1 | 1 |
| Psychosine receptor CHEMBL3714081 | IC50 | 5.4 | 5.4 | 3943.7 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.38 | 5.38 | 4216.0 | 1 |
| G-protein coupled receptor 183 CHEMBL3259470 | IC50 | 5.38 | 5.38 | 4172.2 | 1 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 5.35 | 5.35 | 4490.0 | 1 |
| fMet-Leu-Phe receptor CHEMBL3359 | IC50 | 5.32 | 5.32 | 4803.4 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.32 | 4.7771 | 4800.0 | 7 |
| Trypanosoma cruzi CHEMBL368 | EC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Glucose-dependent insulinotropic receptor CHEMBL5652 | IC50 | 5.29 | 5.29 | 5164.6 | 1 |
| G-protein coupled receptor 35 CHEMBL1293267 | IC50 | 5.22 | 5.22 | 5966.8 | 1 |
| N-formyl peptide receptor 3 CHEMBL5646 | IC50 | 5.21 | 5.21 | 6242.6 | 1 |
| Aldehyde oxidase 1 CHEMBL1641354 | IC50 | 5.21 | 5.21 | 6100.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 4.98 | 4.9533 | 10420.0 | 3 |
| Cytochrome P450 2J2 CHEMBL3491 | IC50 | 4.97 | 4.97 | 10600.0 | 1 |
| ADMET CHEMBL612558 | EC50 | 4.89 | 4.89 | 13000.0 | 1 |
| Ubiquitin-conjugating enzyme E2 N CHEMBL6089 | IC50 | 4.87 | 4.83 | 13424.0 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.86 | 4.86 | 13900.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.79 | 4.79 | 16218.1 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 4.73 | 4.73 | 18500.0 | 1 |
| Ishikawa CHEMBL614649 | IC50 | 4.71 | 4.71 | 19400.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 4.67 | 4.67 | 21300.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 4.64 | 4.64 | 23120.0 | 1 |
| HEC-1-A CHEMBL4296424 | IC50 | 4.63 | 4.63 | 23300.0 | 1 |
| Chikungunya virus CHEMBL4296563 | IC50 | 4.6 | 4.6 | 25100.0 | 1 |
| AN3-CA CHEMBL1075392 | IC50 | 4.59 | 4.59 | 25400.0 | 1 |
| HEC-1B cell line CHEMBL614817 | IC50 | 4.53 | 4.53 | 29800.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.52 | 4.51 | 30370.0 | 2 |
| KLE CHEMBL2366239 | IC50 | 4.51 | 4.51 | 30800.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.46 | 4.46 | 34840.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.45 | 4.45 | 35810.0 | 1 |
| HUVEC CHEMBL613979 | IC50 | 4.01 | 4.01 | 97760.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 27.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 27.0 | mL.min-1.kg-1 | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| Fu | 0.07 | - | Homo sapiens |
| Fu | 0.004 | - | Rattus norvegicus |
| Fu | 0.07 | - | Homo sapiens |
| MRT | 11.0 | hr | Homo sapiens |
| T1/2 | 9.4 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 32527541 | 10.1016/j.bmcl.2020.127239 | Ishikawa | 13 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 32527541 | 10.1016/j.bmcl.2020.127239 | KLE | 11 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 8 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| 18363346 | 10.1021/jm7012453 | Rattus norvegicus | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
Data from ChEMBL 36 via Core Engine